LXRX
USDLexicon Pharmaceuticals Inc. Common Stock
$1.340+0.010 (0.752%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$1.330
High
$1.390
Low
$1.325
Volume
2.72M
Company Fundamentals
Market Cap
487.0M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
2.36M
Exchange
NCM
Currency
USD
52-Week Range
Low $0.28Current $1.340High $1.66
Related News
GlobeNewswire
Data Demonstrating Unique Benefits of Sotagliflozin in Diverse Patient Populations will be Presented at the Hypertrophic Cardiomyopathy Society and American Heart Association's Sessions 2025 in New Orleans
THE WOODLANDS, Texas, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced that data from three studies of sotagliflozin will be presented during upcoming medical meetings. Two
View more
GlobeNewswire
Lexicon Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025
THE WOODLANDS, Texas, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced the Company will release its third quarter 2025 financial results on Thursday, November 6, 2025, prior
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.